![]() |
Volumn 36, Issue 2 SUPPL., 2004, Pages S107-S113
|
Use of cyclosporine in renal transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
BASILIXIMAB;
CYCLOSPORIN;
CYCLOSPORIN A;
DACLIZUMAB;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISOLONE;
PREDNISONE;
RAPAMYCIN;
STEROID;
TACROLIMUS;
CADAVER DONOR;
CALCULATION;
CHRONIC KIDNEY DISEASE;
CLINICAL TRIAL;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MONITORING;
DRUG RESPONSE;
DRUG SAFETY;
DRUG SCREENING;
GRAFT SURVIVAL;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
HYPERTENSION;
HYPERTRIGLYCERIDEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY DYSFUNCTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
META ANALYSIS;
NEPHROTOXICITY;
NEUROTOXICITY;
PRIORITY JOURNAL;
REVIEW;
SIDE EFFECT;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
EID: 1642402941
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.01.064 Document Type: Article |
Times cited : (4)
|
References (87)
|